Clinical Trial Update: Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

This Phase 1 trial studied the combination of dasatinib and all-trans retinoic acid in relapsed/refractory and/or elderly patients with acute myeloid leukemia o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Sprycel (dasatinib)
• Vesanoid (all-trans retinoic acid)

Snippet

Sponsor: University of Pittsburgh | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 1 | Status: COMPLETED